Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Discuss with your psychiatrist
2 people out of 100 who received drug X experienced a heart attack after 3 years 4 people out of 100 who received the placebo experienced a heart attack after 3 years We divide 4/100 to get the baseline absolute risk in this placebo group (often referred to as the control group), which is 4% We then divide 2/100 to get the absolute risk in the group taking the medication (often referred to as the exposure or intervention group), which is 2% To understand the relative risk, we divide the exposed group with the placebo group: 2%/4% = 50% We can then calculate the difference between 2% and 4% to understand the absolute risk, which would be 2% This means that drug X causes a 50% relative drop in the rate of heart attacks compared to the placebo group
Semaglutide is a GLP-1 receptor agonist, which means it mimics the action of the glucagon-like peptide-1 hormone that regulates appetite and food intake
The $245 negotiated price that CMS secured through direct manufacturer discussion also sets an important precedent
Okemos: walkable suburban center near MSU with a mix of home types
10 mg vial reconstitution math BAC water added 1.0 mL Final concentration 10 mg/mL Research amount 1 mg Draw volume 0.10 mL U-100 syringe units 10 units BAC water added 1.0 mL Final concentration 10 mg/mL Research amount 2.5 mg Draw volume 0.25 mL U-100 syringe units 25 units BAC water added 1.0 mL Final concentration 10 mg/mL Research amount 5 mg Draw volume 0.50 mL U-100 syringe units 50 units A 5 mg amount uses half of this vial and requires a 0.50 mL draw at this concentration
